ONDENE FORREST: Open Payments
NPI 1356527139 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 50 payments from 13 companies in 2025. Trend: 2023 $2,120 · 2024 $1,723 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $217 |
| Janssen Biotech, Inc. | 9 | $155 |
| Lilly USA, LLC | 6 | $136 |
| Galderma Laboratories, L.P. | 5 | $129 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| GENZYME CORPORATION | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Amgen Inc. | 1 | $30 |
| UCB, Inc. | 1 | $23 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, NEMLUVIO, EBGLYSS, TALTZ, RINVOQ, ILUMYA.
Industry payments across FL — which companies pay providers there.
